Market Overview –
The Lithotripsy market addresses the growing prevalence of urinary stones worldwide, offering minimally invasive treatment options for kidney and ureteral stones. Lithotripsy is a non-surgical procedure that uses shock waves to fragment stones into smaller pieces, which can then be passed naturally through the urinary tract. Extracorporeal shock wave lithotripsy (ESWL) and intracorporeal lithotripsy techniques, such as laser lithotripsy and pneumatic lithotripsy, are commonly used in clinical practice. With the rising incidence of urinary stone disease due to factors such as dietary habits, dehydration, and metabolic disorders, there's a growing demand for lithotripsy devices and services.
The lithotripsy market is thriving, with a focus on the lithotripsy procedure for treating kidney stones. This non-invasive technique utilizes shock waves to break down stones, offering patients a safer and less invasive alternative to traditional surgery. As awareness of lithotripsy grows, the market for this procedure expands, providing relief to patients worldwide.
Moreover, advancements in lithotripsy technology, such as improved imaging guidance and lithotripter design, are enhancing treatment efficacy and safety profiles. Additionally, the shift towards outpatient and ambulatory lithotripsy procedures is driving market growth by reducing healthcare costs and improving patient access to care. With increasing investments in urological care infrastructure and rising adoption of minimally invasive stone management techniques, the lithotripsy market is expected to witness substantial expansion in the coming years, offering new treatment options for patients with urinary stone disease.
Over the projected period of 2022–2030, the lithotripsy market is anticipated to grow at a 5.80% CAGR to reach USD 2,100 million by 2030.
Segmentation –
The global lithotripsy market has been segmented based on type and end user.
By type, the global lithotripsy market has been segmented into extracorporeal shock wave lithotripsy (ESWL), intracorporeal (endoscopic lithotripsy), percutaneous lithotripsy, and others. The intracorporeal segment has been segmented into laser lithotripsy, electrohydraulic lithotripsy, mechanical lithotripsy, and ultrasonic lithotripsy.
By end user, the global lithotripsy market has been segmented into hospitals and clinics, research laboratories, academic institutes, and others.
Regional Analysis
By region, the global lithotripsy market has been segmented into the Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA).
The Americas is the largest market for lithotripsy and held the largest share of the market in 2016. The widespread prevalence of urology disorders and the presence of a massive pool of diabetic patients in the region drive the Americas market. Moreover, robust healthcare sector, favorable reimbursement scenario, and high healthcare expenditure in the region can be credited for the growth of the market.
Europe commands the second position in the global lithotripsy market where Western Europe accounts for the lion's share of the market. High healthcare expenditure and spreading awareness about new products and therapies in the region can be credited for the growth of the market.
APAC is the fastest growing market for lithotripsy. Expanding healthcare sector, improving reimbursement scenario and the existence of a broad patient base in the region stimulates the growth of the market. The MEA market is expected to grow at a moderate pace over the forecast period.
Regional Analysis –
The lithotripsy market's regional analysis reflects disparities in healthcare access, prevalence of kidney stones, and technological advancements. North America dominates the market, driven by a high incidence of kidney stones and widespread adoption of advanced lithotripsy techniques. Europe follows suit with a strong focus on minimally invasive procedures and innovative lithotripsy devices. In the Asia-Pacific region, rising healthcare expenditure and increasing awareness of kidney stone treatments contribute to market growth. Latin America and Africa are witnessing gradual adoption of lithotripsy procedures, albeit at a slower pace due to limited healthcare infrastructure and awareness. Market players must tailor their strategies to each region's unique needs, considering factors like reimbursement policies, technological advancements, and healthcare infrastructure.
Key Players –
The Lithotripsy companies: Jena Med Tech GmbH (Germany), Medispec LTD (US), Olympus Corporation (Japan), Siemens Healthcare GmbH (Germany), STORZ MEDICAL AG (Switzerland), Elmed Electronics & Medical Industry & Trade Inc. (Turkey), Boston Scientific (US), DIREX, S.L. (Spain), Dornier MedTech (Germany), EDAP TMS (France), and In order to have a deeper understanding of the market and industry performance, the Lithotripsy Market study from Market Research Future includes substantial primary research in addition to a thorough analysis of both qualitative and quantitative elements by a number of industry professionals and important opinion leaders. The report provides a comprehensive overview of the current market environment, taking into account technical advancements, macroeconomic factors, historical and forecast market size in terms of value and volume, and market regulating factors.
Related Reports –
Americas Healthcare Human Resources Software
For more information visit at MarketResearchFuture
English